Clay, E., Jamotte, A., Verhamme, P., Cohen, A. T., Hout, B. A. V., & Gumbs, P. Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK. MDPI AG.
Chicago Style (17th ed.) CitationClay, Emilie, Aurélien Jamotte, Peter Verhamme, Alexander T. Cohen, Ben. A. Van Hout, and Pearl Gumbs. Cost-effectiveness of Edoxaban Compared to Warfarin for the Treatment and Secondary Prevention of Venous Thromboembolism in the UK. MDPI AG.
MLA (9th ed.) CitationClay, Emilie, et al. Cost-effectiveness of Edoxaban Compared to Warfarin for the Treatment and Secondary Prevention of Venous Thromboembolism in the UK. MDPI AG.
Warning: These citations may not always be 100% accurate.